v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A and Class B Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2024   342,118,782      
Beginning balance at Dec. 31, 2024 $ 2,714,363 $ 3 $ 2,689,013 $ (4,701) $ 30,048
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   2,711,540      
Issuance of common stock upon exercise of stock options 3,312   3,312    
Vesting of restricted and performance stock units (in shares)   2,726,059      
Issuance of restricted shares of common stock from acquisitions (in shares)   771,355      
Issuance of restricted shares of common stock from acquisitions 53,038   53,038    
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   287,014      
Issuance of common stock under the Employee Stock Purchase Plan 28,578   28,578    
Stock-based compensation 356,346   356,346    
Settlement of common stock in connection with the 2025 Convertible Senior Notes (in shares)   (6,169,000)      
Settlement of common stock in connection with the 2025 Convertible Senior Notes (157)   (157)    
Change in accumulated other comprehensive (loss) income 12,988     12,988  
Net income 27,289       27,289
Ending balance (in shares) at Jun. 30, 2025   348,608,581      
Ending balance at Jun. 30, 2025 3,195,757 $ 3 3,130,130 8,287 57,337
Beginning balance (in shares) at Mar. 31, 2025   344,910,809      
Beginning balance at Mar. 31, 2025 2,916,674 $ 3 2,860,643 1,338 54,690
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1,395,407      
Issuance of common stock upon exercise of stock options 1,609   1,609    
Vesting of restricted and performance stock units (in shares)   1,250,165      
Issuance of restricted shares of common stock from acquisitions (in shares)   771,355      
Issuance of restricted shares of common stock from acquisitions 53,038   53,038    
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   287,014      
Issuance of common stock under the Employee Stock Purchase Plan 28,578   28,578    
Stock-based compensation 186,419   186,419    
Settlement of common stock in connection with the 2025 Convertible Senior Notes (in shares)   (6,169)      
Settlement of common stock in connection with the 2025 Convertible Senior Notes (157)   (157)    
Change in accumulated other comprehensive (loss) income 6,949     6,949  
Net income 2,647       2,647
Ending balance (in shares) at Jun. 30, 2025   348,608,581      
Ending balance at Jun. 30, 2025 3,195,757 $ 3 3,130,130 8,287 57,337
Beginning balance (in shares) at Dec. 31, 2025   352,525,971      
Beginning balance at Dec. 31, 2025 $ 3,732,206 $ 3 3,579,010 15,404 137,789
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,864,259 1,864,259      
Issuance of common stock upon exercise of stock options $ 12,432   12,432    
Vesting of restricted and performance stock units (in shares)   3,560,961      
Issuance of restricted shares of common stock from acquisitions (in shares)   750,624      
Issuance of restricted shares of common stock from acquisitions 75,327   75,327    
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   254,970      
Issuance of common stock under the Employee Stock Purchase Plan 39,067   39,067    
Stock-based compensation 433,164   433,164    
Change in accumulated other comprehensive (loss) income (22,168)     (22,168)  
Net income 97,132       97,132
Ending balance (in shares) at Jun. 30, 2026   358,956,785      
Ending balance at Jun. 30, 2026 4,367,160 $ 3 4,139,000 (6,764) 234,921
Beginning balance (in shares) at Mar. 31, 2026   355,845,568      
Beginning balance at Mar. 31, 2026 3,988,222 $ 3 3,801,272 (3,416) 190,363
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   570,343      
Issuance of common stock upon exercise of stock options 2,718   2,718    
Vesting of restricted and performance stock units (in shares)   1,669,516      
Issuance of restricted shares of common stock from acquisitions (in shares)   616,388      
Issuance of restricted shares of common stock from acquisitions 68,810   68,810    
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   254,970      
Issuance of common stock under the Employee Stock Purchase Plan 39,067   39,067    
Stock-based compensation 227,133   227,133    
Change in accumulated other comprehensive (loss) income (3,348)     (3,348)  
Net income 44,558       44,558
Ending balance (in shares) at Jun. 30, 2026   358,956,785      
Ending balance at Jun. 30, 2026 $ 4,367,160 $ 3 $ 4,139,000 $ (6,764) $ 234,921